| 000 | 01088nab a2200241 c 4500 | ||
|---|---|---|---|
| 999 |
_c143559 _d143559 |
||
| 003 | ES-MaIEF | ||
| 005 | 20220728113849.0 | ||
| 007 | ta | ||
| 008 | 210209t2020 us ||||| |||| 00| 0|eng d | ||
| 040 |
_aES-MaIEF _bspa _cES-MaIEF |
||
| 100 | 1 |
_aHorst, Thomas _921782 |
|
| 245 | 0 |
_aEffective tax rates for the 10 largest pharma MNEs and their implications for U.S. international tax reform _c by Thomas Horst |
|
| 260 | _c2020 | ||
| 500 | _aDisponible también en formato electrónico. | ||
| 500 | _aResumen. | ||
| 520 | _aIn this article, the author analyzes financial data and effective tax rates for the largest U.S. and international multinational pharmaceutical corporations and considers the implications of those statistical results for U.S. tax reform. | ||
| 650 | 4 |
_943600 _aEMPRESAS MULTINACIONALES |
|
| 650 | 4 |
_943550 _aEMPRESAS FARMACEUTICAS |
|
| 650 | 4 |
_aIMPUESTOS _947460 |
|
| 650 | 4 |
_aESTADOS UNIDOS _942888 |
|
| 773 | 0 |
_9164259 _oOP 138-Bis/2020/100/12 _tTax Notes International _w(IEF)124525 _x 1048-3306 _gv. 100, n. 12, December 21, 2020, p. 1683-1694 |
|
| 942 | _cART | ||